Latest in Research & Development

New Osaka-developed reverse genetics system accelerates norovirus vaccine and drug research

Osaka University scientists have created the first simple, efficient system to generate infectious human noroviruses, paving the way for faster antiviral screening and vaccine development

Find out more

Grace and Molecule.One join forces to transform peptide building block synthesis with AI

The pair have entered into a multi-year strategic agreement to accelerate drug development timelines, strengthen US manufacturing capabilities and help bring lifesaving...
See more

Chemify secures $1.6m Gates Foundation grant to accelerate digital chemistry for tuberculosis drug discovery

The follow-on funding supports Chemify and Lgenia in designing and synthesising new small-molecule candidates for high-priority TB targets using Chemify’s AI-driven digital chemistry platform

GlaxoSmithKline and Oxford BioTherapeutics partner to advance antibody-based therapeutics for cancer

The collaboration leverages OBT's proprietary OGAP-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targets

PLL Therapeutics opens New Zealand subsidiary to accelerate ALS clinical research in Asia-Pacific

The new entity will support Phase II ALS patient recruitment in New Zealand (where incidence rates exceed the global average) and expand PLL Therapeutics’ footprint in the Asia-Pacific neurodegenerative disease research landscape

Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme

Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research programme titled RISE (Reducing Immune Stress from Excess cytokine release in advanced therapies)

Lilly’s Jaypirca outperforms Imbruvica in landmark Phase III CLL trial, showing higher response rates and strong PFS trend

Pirtobrutinib met its primary endpoint and delivered higher overall response rates than ibrutinib in the BRUIN CLL-314 study, with early progression-free survival data also favouring Lilly’s next-generation BTK inhibitor

Global myalgic encephalomyelitis study identifies 250+ core genes and shared biology with long COVID

PrecisionLife’s large-scale genomic analysis reveals major biological drivers of ME and its overlap with long COVID, identifying dozens of drug repurposing opportunities and paving the way for more targeted clinical trials

Servier and University College London partner to advance research in rare genetic epileptic disorders

Servier will collaborate with UCL to evaluate antisense oligonucleotide candidates in cutting-edge brain assembloid models, aiming to accelerate therapeutic advances for patients with developmental and epileptic encephalopathy (DEE)

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Latest posts in Research & Development

EU chemicals reforms rarely reflected in pharmaceutical policy, new study finds

A new analysis shows major EU Green Deal-driven chemicals legislation changes are seldom integrated into pharmaceutical policy, highlighting the need for closer alignment between health and environmental regulation

Experts uncover how bacteria modify themselves to outsmart antibiotics

Scientists from the University of Nottingham are part of an international collaboration which has taken a step closer to understanding why bacteria can become resistant to antibiotics

€2.5m boost for SensABLATE to revolutionise real-time lung cancer treatment

The next-generation AI and photonics system is designed to provide instant intraoperative confirmation during lung cancer ablation and aims to improve precision, reduce repeat procedures and enhance patient outcomes

FDA grants Medivir’s MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta treatment

The FDA has awarded Orphan Drug Designation to Medivir’s selective cathepsin K inhibitor MIV-711 for Osteogenesis Imperfecta, a rare genetic bone disorder, after preclinical and clinical data suggests the therapy may strengthen bone

Vivan Therapeutics and MRC LMS launch partnership to study how KRAS mutations, diabetes and diet shape cancer drug response

The new collaboration will investigate how KRAS mutations and metabolic conditions such as diabetes influence chemotherapy effectiveness, using high-throughput in vivo “fly avatar” models

Gates Foundation awards Keltic Pharma $1.3 million for malaria drug research

The University of Glasgow spin-out's malaria programme is moving towards IND enablement within the next 12 months and is designed to deliver a single-dose cure — a potential breakthrough in efforts to combat one of the world’s most lethal diseases

BioMed X announces neuroscience research partnership with AbbVie

The new project, taking place at BioMed X's institute in New Haven, will aim to uncover the mechanisms of anhedonia and identify novel therapeutic targets

Bracco, Limula and the University of Fribourg partner to advance next-gen cell and gene therapy manufacturing in Switzerland

A new Swiss industry–academia collaboration aims to improve CAR-T and cell therapy production by combining Bracco’s microbubble technology with Limula’s automated processing platform

Novo Nordisk’s oral semaglutide fails to slow Alzheimer’s progression in global Phase III trials

The studies showed no statistically significant benefit on disease progression despite biomarker improvements, leading to a sharp drop in the company's share price

Bayer expands global partnership with TetraScience to accelerate AI-driven scientific data management

Bayer is scaling TetraScience’s Scientific Data Foundry across its pharma and crop science R&D teams to unify and harmonise laboratory and CRO data. The expansion aims to streamline regulatory workflows and enable faster, AI-ready analysis across global programmes

ChristianaCare launches organoid core to personalise cancer treatment in Delaware

The new facility at the Helen F. Graham Cancer Center grows patient-derived mini-tumours to test therapies, helping doctors tailor cancer treatments and accelerate translational research in a community setting

Sponsor content

Titan Enterprises highly commended for Manufacturer of the Year at industry awards

Recognition reflects the company’s investment in innovation and precision flow measurement

Free online course introduces fundamentals of SFC

Learn how SFC can improve efficiency and reduce environmental impact

Thermo Fisher launches general purpose centrifuges with natural refrigerant cooling

New X and S Series models offer high performance with reduced environmental impact

Work safely with hazardous substances – new Asecos catalogue available now

Asecos cabinets help minimise risks when storing flammable substances

Redefining QP training for today’s professionals

How NSF is making specialist learning more flexible and accessible

NSF’s QP training program combines technical skill with personalised guidance

A mentoring-led approach supporting delegates through every stage of the QP journey

SU Puresonic ultrasonic sensor ensures precise hygienic flow measurement

Innovative design meets the highest standards in food, pharma, and water treatment

Abzena advances ADC development with ThioBridge conjugation technology

Next-generation conjugation delivers greater stability, potency and control for targeted cancer therapeutics

Guardtech supporting malaria fight in East Africa with portable 11-bay lab

Suffolk-based experts provide Cleancube Multi 11 for Oxitec’s Friendly mosquito programme in Djibouti

Optimising sample traceability with laser marking technology

Speed and precision in high-throughput tube identification

Flowchem teaching manual now available to download

Guide offers step-by-step instructions for ten reactions including Nobel Prize-winning examples

Cut Argon use and costs with Shimadzu’s ICPMS-2040/2050

New Mini-Torch System offers precision analysis with 40% less Argon

Featured companies

CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and... At Vileda Professional CE we develop and manufacture leading edge cleaning solutions for professional users in various application areas, such as Healthcare and Controlled... Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more